<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="62071">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01908036</url>
  </required_header>
  <id_info>
    <org_study_id>FITBIT2</org_study_id>
    <nct_id>NCT01908036</nct_id>
  </id_info>
  <brief_title>Use of a Monitor in ME/CFS</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York CFS Association</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>New York CFS Association</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of an activity monitor to determine increase or decrease of activity in patients
      suffering from chronic fatigue syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A cohort of 50 patients suffering from chronic fatigue syndrome will be given an informed
      release form. Have a signed the informed release they will be  given a Fitbit activity
      monitor. These monitors will be evaluated on a weekly interval by computer interface. The
      activity will be calculated to determine the online of activity and whether there is
      increase or decrease in activity during the time of the study. The study is an observational
      rather than  an interventional study. There is no invasion or intervention in the patient's
      normal activities
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>observation of activity level in CFS patients</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>observation of activity level in CFS patients using objective activity monitor</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Chronic Fatigue Syndrome</condition>
  <eligibility>
    <study_pop>
      <textblock>
        50 CFS patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Fukuda and Canadian consensus criteria for the diagnosis of chronic fatigue syndrome

        Exclusion Criteria:

        Acute disease and exclusion conditions in Fukuda criteria
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>derek enlander, MD</last_name>
    <phone>2127942000</phone>
    <email>denlander@aol.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Me/Cfs Center,860 Fifth Avenue</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Derek enlander, MD</last_name>
      <phone>212-794-2000</phone>
      <email>denlander@aol.com</email>
    </contact>
    <investigator>
      <last_name>derek enlander, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 24, 2013</lastchanged_date>
  <firstreceived_date>July 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic fatigue syndrome</keyword>
  <keyword>CFS</keyword>
  <keyword>myalgic encephalomyelitis</keyword>
  <keyword>M.E.</keyword>
  <keyword>activity monitor</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fatigue</mesh_term>
    <mesh_term>Fatigue Syndrome, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
